Global Digital Respiratory Devices Market: Focus on Sensors, Smart Inhalers and Nebulizers, Application, 9 Countries Data, and Competitive Landscape – Analysis and Forecast, 2021-2030

$5000$8000

Global Digital Respiratory Devices Market to Reach $405.1 Million by 2030

Description

Market Report Coverage – Digital Respiratory Devices

Market Segmentation

• By Product (Sensors and Apps, and Smart Inhalers and Nebulizers)
• By Indication (Asthma and Chronic Obstructive Pulmonary Disease)

Regional Segmentation

• North America – U.S., and Canada
• Europe – Germany, U.K., France, Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, and Rest-of-Asia-Pacific
• Rest-of-the-World

Growth Drivers

• Increasing prevalence of respiratory diseases
• Increasing adoption of digital technology among individuals
• Treatment satisfaction with inhaled therapy among individuals

Market Restraints

• Issues related to the accuracy and reliability of the device
• Availability and high cost associated with digital respiratory devices

Market Opportunities

• Expansion into the emerging markets
• Predicting future exacerbations

Key Companies Profiled

3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp. z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.

Key Questions Answered in this Report:

• How pharmaceutical companies are capitalizing on the opportunity for connected inhalers to improve drug sales?
• What has been the impact of the COVID-19 pandemic on global digital respiratory devices market?
• What are the potential recovery scenarios of the market from the COVID-19 pandemic, and how can it impact the market forecast?
• How will the pharma industry evolve in terms of drug-based devices in the future?
• What are the potential business models in global digital respiratory devices market?
• What are the major market drivers, challenges, and opportunities in the global digital respiratory devices market?
• What are the underlying structures resulting in the emerging trends within the digital respiratory devices industry?
• What was the market value of the leading segments and sub-segments of the global digital respiratory devices market in 2021?
• How is each segment of the global digital respiratory devices market expected to grow during the forecast period and what is the revenue anticipated to be generated by each of the segments by the end of 2030?
• What are the influencing factors that may affect the market share of the key players?
• What is the market share of each of the companies in the global digital respiratory devices market and what are their contributions?

Key USPs of the Report

Following are some of the key contents of the report:

• Porter’s five forces analysis
This section includes exhaustive information on the competitive intensity of the market which helps any firm to understand the market, the competitors entering or leaving the market, and the firm’s competitive strategy to operate in the market.

• Business Model Analysis
This section comprises information on the key business models deployed in the market by leading players.

• Impact of COVID-19
This section of the report encompasses the following:
o Impact on digital respiratory devices Demand and Supply
o Future Impact (Short-, mid-, and long-term)
o Entry Barrier and Opportunities for New Entrants

In addition, the report provides:

• A detailed analysis and growth forecast (2021-2030) for different indications
• Recent developments and trends in the global market landscape
• Factors promoting and inhibiting the market growth

Expert Quote

“Lack of consumer awareness is a key barrier to market entry for new players. Digital awareness among consumers is in the process of growth. However, more awareness needs to be created for the same. The lack of an established consumer base can hamper a start-up’s ability to enter the market due to low confidence on business viability and returns.”

Scope of the Global Digital Respiratory Devices Market

The purpose of the study is to enable the reader to gain a holistic view of the Global Digital Respiratory Devices Market by each of the aforementioned segments.

The report constitutes an in-depth analysis of the global digital respiratory devices market, including a thorough analysis of the different end-users. The study also provides exhaustive information on competitive landscape, brand share landscape, market share of the leading players, as well as other vital information with respect to the global digital respiratory devices market. The report considers sensors and apps, and smart inhalers and nebulizers.

Key Companies in the Global Digital Respiratory Devices Market

Some of the key players contributing to the Global Digital Respiratory Devices Market include 3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp. z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Base Year

2021

Base Market Size

$46.1 Million in 2021

Currency/Unit

USD

Forecast Year

2030

Market Size Forecast

$405.1 Million by 2030

CAGR

27.31%

Table of Contents

1 Market Overview 1.1 Introduction 1.2 Digital Respiratory Devices Market Ecosystem 1.3 Assumptions and Limitations 2 Market Dynamics 2.1 Impact Analysis 2.2 Market Drivers 2.2.1 Increasing Prevalence of Respiratory Diseases 2.2.2 Increasing Adoption of Digital Technology Among Individuals 2.2.3 Treatment Satisfaction with Inhaled Therapy Among Individuals 2.3 Market Restraints 2.3.1 Issues Related to The Accuracy and Reliability of the Device 2.3.2 Availability and High Cost Associated with Digital Respiratory Devices 2.4 Market Opportunities 2.4.1 Expansion into the Emerging Markets 2.4.2 Predicting Future Exacerbations 3 Analysis of COVID-19 Impact on Global Digital Respiratory Devices Market 3.1 Impact on Market Size 3.1.1 Scenario Comparative Analysis (Pre-COVID-19, During-COVID-19, Post-COVID-19) 3.1.2 Regional Impact 3.1.2.1 North America 3.1.2.2 Europe 3.1.2.3 Asia-Pacific 3.2 Impact on Digital Respiratory Devices Adoption 3.2.1 Short-Term Impact (2-4 Years) 3.2.2 Mid-Term Impact (5-8 Years) 3.2.3 Long-Term Impact (9-12 Years) 3.3 Entry Barrier and Opportunities for New Entrants 4 Competitive Landscape 4.1 Key Developments and Strategies 4.1.1 Agreements and Collaborations 4.1.2 Regulatory and Legal Activities 4.1.3 Investments, Funding, and Business Expansion 4.1.4 Mergers and Acquisitions 4.1.5 Awards and Recognitions 4.1.6 Product Launches 4.2 Market Share Analysis 4.3 Industry Attractiveness 4.3.1 Bargaining Power of Suppliers 4.3.2 Bargaining Power of Buyer 4.3.3 Threat of New Entrants 4.3.4 Threat of Substitute Products 4.3.5 Intensity of Competitive Rivalry 5 Industry Insights 5.1 Opportunity Map Analysis of Smart Inhalers and Nebulizers 5.2 Smart Inhaler Value Propositions for Stakeholders 5.3 Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in Individuals 5.4 Business Models for Digital Respiratory Devices Market 6 Global Digital Respiratory Devices Market (by Product Type) 6.1 Sensors and Apps 6.2 Smart Inhalers and Nebulizers 7 Global Digital Respiratory Devices Market (by Indication) 7.1 Asthma 7.2 Chronic Obstructive Pulmonary Disease (COPD) 8 Global Digital Respiratory Devices Market (by Region) 8.1 North America 8.1.1 U.S. 8.1.2 Canada 8.2 Europe 8.2.1 Germany 8.2.2 U.K. 8.2.3 France 8.2.4 Rest-of-Europe 8.3 Asia-Pacific (APAC) 8.3.1 Japan 8.3.2 China 8.3.3 Australia 8.3.4 India 8.3.5 Rest-of-Asia-Pacific (RoAPAC) 8.4 Rest-of-the-World (RoW) 9 Company Profiles 9.1 3M Health Care Limited 9.1.1 Company Overview 9.1.2 Role of 3M Health Care Limited in the Global Digital Respiratory Devices Market 9.1.3 Financials 9.1.3.1 Key Insights on the Financial Health of the Company 9.1.4 SWOT Analysis 9.2 Adherium Limited 9.2.1 Company Overview 9.2.2 Role of Adherium Limited in the Global Digital Respiratory Devices Market. 9.2.3 Financials 9.2.3.1 Key Insights on the Financial Health of the Company 9.2.4 SWOT Analysis 9.3 Amiko Digital Health Limited 9.3.1 Company Overview 9.3.2 Role of Amiko Digital Health Limited in the Global Digital Respiratory Devices Market 9.3.3 SWOT Analysis 9.4 AstraZeneca plc 9.4.1 Company Overview 9.4.2 Role of AstraZeneca plc in the Global Digital Respiratory Devices Market 9.4.3 Financials 9.4.3.1 Key Insights on the Financial Health of the Company 9.4.4 SWOT Analysis 9.5 Boehringer Ingelheim International GmbH 9.5.1 Company overview 9.5.2 Role of Boehringer Ingelheim International GmbH in the Global Digital Respiratory Devices Market 9.5.3 Financials 9.5.3.1 Key Insights on the Financial Health of the Company 9.5.4 SWOT Analysis 9.6 Capsule Technologies, Inc. 9.6.1 Company Overview 9.6.2 Role of Capsule Technologies, Inc. in the Global Digital Respiratory Devices Market. 9.6.3 SWOT Analysis 9.7 Cognita Labs 9.7.1 Company Overview 9.7.2 Role of Cognita Labs in the Global Digital Respiratory Devices Market 9.7.3 SWOT Analysis 9.8 Cohero Health 9.8.1 Company Overview 9.8.2 Role of Cohero Health in the Global Digital Respiratory Devices Market 9.8.3 SWOT Analysis 9.9 Findair Sp. z. o. o 9.9.1 Company Overview 9.9.2 Role of Findair Sp. z. o. o in the Global Digital Respiratory Devices Market 9.9.3 SWOT Analysis 9.1 GlaxoSmithKline plc 9.10.1 Company overview 9.10.2 Role of GlaxoSmithKline plc in the Global Digital Respiratory Devices Market 9.10.3 Financials 9.10.3.1 Key Insights on the Financial Health of the Company 9.10.4 SWOT Analysis 9.11 Novartis AG 9.11.1 Company overview 9.11.2 Role of Novartis AG in the Global Digital Respiratory Devices Market 9.11.3 Financials 9.11.3.1 Key Insights on the Financial Health of the Company 9.11.4 SWOT Analysis 9.12 Pneuma Respiratory, Inc. 9.12.1 Company Overview 9.12.2 Role of Pneuma Respiratory, Inc. in the Global Digital Respiratory Devices Market 9.12.3 SWOT Analysis 9.13 Propeller Health 9.13.1 Company Overview 9.13.2 Role of Propeller Health in the Global Digital Respiratory Devices Market 9.13.3 SWOT Analysis 9.14 Sensirion AG 9.14.1 Company overview 9.14.2 Role of Sensirion AG in the Global Digital Respiratory Devices Market 9.14.3 Financials 9.14.3.1 Key Insights on the Financial Health of the Company 9.14.4 SWOT Analysis 9.15 Teva Pharmaceuticals Industries Ltd. 9.15.1 Company Overview 9.15.2 Role of Teva Pharmaceuticals Industries Ltd. in the Global Digital Respiratory Devices Market 9.15.3 Financials 9.15.3.1 Key Insights on the Financial Health of the Company 9.15.4 SWOT Analysis 10 Research Scope and Methodology 10.1 Product Definition 10.2 Scope of the Research Study List of Tables Table 1: Research and Facilitation Framework Table 2: Global Digital Respiratory Devices Market Dynamic Impact Analysis Table 2.1: Impact Analysis of Global Digital Respiratory Devices Market Table 2.2: Incidence of Asthma in Key Countries, 2017-2019 Table 2.3: Incidence of COPD in Key Countries, 2017-2019 Table 3.1: Global Digital Respiratory Devices Market: Barriers to Entry Table 5.1: Smart Inhaler Value Propositions for Stakeholders Table 5.2: Different Data Revenue Streams Table 6.1: Global Digital Respiratory Devices Market: Smart Inhalers in Pipeline Table 7.1: Incidence of Asthma in Key Countries, 2017-2019 Table 7.2: Incidence of COPD in Key Countries, 2017-2019 List of Figures Figure 1: Opportunities for Clinical Benefit Figure 2: Global Digital Respiratory Devices Market, 2018-2030 Figure 3: Global Digital Respiratory Devices Market: Dominating Segment, 2019 and 2030 Figure 4: Global Digital Respiratory Devices Market (by Product Type), 2019 and 2030 Figure 5: Global Digital Respiratory Devices Market (by Indication), 2019 and 2030 Figure 6: Global Digital Respiratory Devices Market (by Region), 2019 and 2030 Figure 7: Global Digital Respiratory Devices: Strategies Incorporated to Expand Global Reach Figure 8: Go-To-Market Strategy Figure 1.1: Digital Respiratory Devices Market Workflow Figure 1.2: Smart Inhalers and Data Flow Figure 1.3: Digital Respiratory Devices Market Ecosystem Figure 3.1: Global Digital Respiratory Devices Market: Scenario Comparative Analysis Figure 3.2: COVID-19 Trend (Daily Cases), December 31, 2019-December 14, 2020 Figure 3.3: Global Digital Respiratory Devices Market COVID-19 Impact (by Key Regions), 2019-2030 Figure 3.4: Potential COVID-19 Recovery Scenarios Figure 3.5: Global Prevalence (Asthma and COPD) Historical and Forecast Growth Rates, 1990-2032 Figure 3.6: Global Digital Respiratory Diseases Market: Opportunities for New Players Figure 4.1: Competitive Landscape, January 2015-March 2021 Figure 4.2: Share of Key Developments and Strategies, January 2015-March 2021 Figure 4.3: Agreements and Collaborations Share (by Company), January 2015 - March 2021 Figure 4.4: Regulatory and Legal Activities Share (by Company), January 2015- March 2021 Figure 4.5: Investments, Funding, and Business Expansions Share (by Company), January 2015-March 2021 Figure 4.6: Mergers and Acquisitions Share (by Company), January 2015- March 2021 Figure 4.7: Awards and Recognitions Share (by Company), January 2015-March 2021 Figure 4.8: Product Launches Share (by Companies), January 2015-March 2021 Figure 4.9: Global Digital Respiratory Devices Market Share Analysis, 2018 and 2019 Figure 4.10: Porter’s Five Forces Analysis Figure 4.11: Bargaining Power of Suppliers: Overall Impact, 2018-2030 Figure 4.12: Bargaining Power of Buyers: Overall Impact, 2018-2030 Figure 4.13: Threat of New Entrant: Overall Impact, 2018-2030 Figure 4.14: Threat of Substitute Products: Overall Impact, 2018-2030 Figure 4.15: Intensity of Competitive Rivalry: Overall Impact, 2018-2030 Figure 5.1: Global Digital Respiratory Devices Market: Opportunity Map Analysis Figure 5.2: Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in Individuals Figure 6.1: Global Digital Respiratory Devices Market (by Product Type) Figure 6.2: Global Digital Respiratory Devices Market Share (by Product Type), 2019 and 2030 Figure 6.3: Global Digital Respiratory Devices Market (Sensors and Apps), $Million, 2018-2030 Figure 6.4: Global Digital Respiratory Devices Market (Smart Inhalers and Nebulizers), $Million, 2018-2030 Figure 7.1: Global Digital Respiratory Devices Market (by Indication) Figure 7.2: Global Digital Respiratory Devices Market Share (by Indication), 2019 and 2030 Figure 7.3: Global Digital Respiratory Devices Market (Asthma), $Million, 2018-2030 Figure 7.4: Global Digital Respiratory Devices Market (COPD), $Million, 2018-2030 Figure 8.1: Global Digital Respiratory Devices Market (by Region) Figure 8.2: Global Digital Respiratory Devices Market (by Region), $Million, 2018-2030 Figure 8.3: North America Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.4: North America Digital Respiratory Devices Market (by Country), $Million, 2018-2030 Figure 8.5: U.S. Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.6: Canada Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.7: Europe Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.8: Europe Digital Respiratory Devices Market (by Country), $Million, 2018-2030 Figure 8.9: Germany Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.10: U.K. Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.11: France Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.12: Rest-of-Europe Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.13: Asia-Pacific Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.14: Asia-Pacific Digital Respiratory Devices Market (by Country), 2018-2030 Figure 8.15: Japan Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.16: China Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.17: Australia Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.18: India Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.19: Rest-of-Asia-Pacific Digital Respiratory Devices Market, $Million, 2018-2030 Figure 8.20: Rest-of-the-World Digital Respiratory Devices Market, $Million, 2018-2030 Figure 9.1: Shares of Company Profiles Figure 9.2: 3M Health Care Limited: Overall Product Portfolio Figure 9.3: 3M Health Care Limited: Overall Financials, 2018-2020 Figure 9.4: 3M Health Care Limited: Revenue (by Business Segment), 2018-2020 Figure 9.5: 3M Health Care Limited: Revenue (by Region), 2018-2020 Figure 9.6: 3M Health Care Limited: R& D Expense, 2018-2020 Figure 9.7: 3M Health Care Limited: SWOT Analysis Figure 9.8: Adherium Limited: Overall Product Portfolio Figure 9.9: Adherium Limited: Overall Financials, 2018-2020 Figure 9.10: Adherium Limited: R& D Expense, 2018-2020 Figure 9.11: Adherium Limited: SWOT Analysis Figure 9.12: Amiko Digital Health Limited: Overall Product Portfolio Figure 9.13: Amiko Digital Health Limited: SWOT Analysis Figure 9.14: AstraZeneca plc: Overall Product Portfolio Figure 9.15: AstraZeneca plc: Overall Financials, 2018-2020 Figure 9.16: AstraZeneca plc: Net Revenue (by Region), 2018-2020 Figure 9.17: AstraZeneca plc: R& D Expense, 2018-2020 Figure 9.18: AstraZeneca plc: SWOT Analysis Figure 9.19: Boehringer Ingelheim International GmbH: Product Offerings Figure 9.20: Boehringer Ingelheim International GmbH: Overall Financials, 2017-2019 Figure 9.21: Boehringer Ingelheim International GmbH Net Revenue (by Business Segment), 2017-2019 Figure 9.22: Boehringer Ingelheim International GmbH: Net Revenue (by Region), 2017-2019 Figure 9.23: Boehringer Ingelheim International GmbH: R& D Expense, 2017-2019 Figure 9.24: AstraZeneca plc: SWOT Analysis Figure 9.25: Capsule Technologies, Inc.: SWOT Analysis Figure 9.26: Cognita Labs: Overall Product Portfolio Figure 9.27: Cohero Health: SWOT Analysis Figure 9.28: Cohero Health: Overall Product Portfolio Figure 9.29: Cohero Health: SWOT Analysis Figure 9.30: Findair Sp. z. o. o: Overall Product Portfolio Figure 9.31: Findair Sp. z. o. o: SWOT Analysis Figure 9.32: GlaxoSmithKline plc: Product Offerings Figure 9.33: GlaxoSmithKline plc: Overall Financials, 2018-2020 Figure 9.34: GlaxoSmithKline plc Net Revenue (by Business Segment), 2018-2020 Figure 9.35: GlaxoSmithKline plc: Net Revenue (by Region), 2018-2020 Figure 9.36: GlaxoSmithKline plc: R& D Expense, 2018-2020 Figure 9.37: GlaxoSmithKline plc: SWOT Analysis Figure 9.38: Novartis AG: Product Offerings Figure 9.39: Novartis AG: Overall Financials, 2018-2020 Figure 9.40: Novartis AG: Net Revenue (by Business Segment), 2018-2020 Figure 9.41: Novartis AG: Net Revenue (by Region), 2018-2020 Figure 9.42: Novartis AG: R&D Expense, 2018-2020 Figure 9.43: Novartis AG: SWOT Analysis Figure 9.44: Pneuma Respiratory, Inc.: Overall Product Portfolio Figure 9.45: Pneuma Respiratory, Inc.: SWOT Analysis Figure 9.46: Propeller Health: Product Offerings for Digital Respiratory Devices Market Figure 9.47: Propeller Health: SWOT Analysis Figure 9.48: Sensirion AG: Overall Product Portfolio Figure 9.49: Sensirion AG: Overall Financials, 2017-2019 Figure 9.50: Sensirion AG: Net Revenue (by Business Segment), 2017-2019 Figure 9.51: Sensirion AG: Net Revenue (by Region), 2017-2019 Figure 9.52: Sensirion AG: R&D Expense, 2017-2019 Figure 9.53: Sensirion AG: SWOT Analysis Figure 9.54: Product Offerings for Global Digital Respiratory Devices Market Figure 9.55: Teva Pharmaceuticals Industries Ltd.: Net Revenue (by Business Segment), 2017-2019 Figure 9.56: Teva Pharmaceuticals Industries Ltd.: Net Revenue (by Region), 2017-2019 Figure 9.57: Teva Pharmaceuticals Industries Ltd.: R& D Expense, 2017-2019 Figure 9.58: Teva Pharmaceuticals Industries Ltd.: SWOT Analysis Figure 10.1: Global Digital Respiratory Devices Market Segmentation Figure 10.2: Research Methodology Figure 10.3: Primary Research Figure 10.4: Secondary Research Figure 10.5: Data Triangulation Figure 10.6: Bottom-up Approach (Segment-wise Analysis) Figure 10.7: Top-down Approach (Segment-wise Analysis) Figure 10.8: Assumptions and Limitations Figure 10.9: Considered Factors for Data Prediction and Modelling

Reviews

There are no reviews yet.

Be the first to review “Global Digital Respiratory Devices Market: Focus on Sensors, Smart Inhalers and Nebulizers, Application, 9 Countries Data, and Competitive Landscape – Analysis and Forecast, 2021-2030”